Registration No.:	PI/2007/X/643/MP
Name:	Vivek Kumar
M.S.(Pharm.) Thesis Title:	Targeting MurB enzyme of Mycobacterium tuberculosis: A Structural Bioinformatics Approach
Connect at:	Linkedin
Research: 6
Kumar V and Sobhia ME. Characterisation of the flexibility of substrate binding loop in the binding of direct InhA inhibitors. International Journal of Computational Biology and Drug Design 2013, 6: 318-342.
Arvind A, Kumar V, Saravanan P and Mohan CG. Homology modeling, molecular dynamics and inhibitor binding study on MurD ligase of Mycobacterium tuberculosis. Interdisciplinary Sciences-Computational Life Sciences 2012, 4: 223-238.
Hymavati, Kumar V and Sobhia ME. Implication of crystal water molecules in inhibitor binding at ALR2 active site. Computational and Mathematical Methods in Medicine 2012, 2012: Article ID 541594.
Gautam R, Jachak SM, Kumar V and Mohan CG. Synthesis, biological evaluation and molecular docking studies of stellatin derivatives as cyclooxygenase (COX-1, COX-2) inhibitors and anti-inflammatory agents. Bioorganic & Medicinal Chemistry Letters 2011, 21: 1612-1616.
Kumar V, Saravanan P, Arvind A and Mohan CG. Identification of hotspot regions of MurB oxidoreductase enzyme using homology modeling, molecular dynamics and molecular docking techniques. Journal of Molecular Modeling 2011, 17: 939-953.
Awale M, Kumar V, Saravanan P and Mohan CG. Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors. Journal of Molecular Modeling 2010, 16: 475-488.
Books/Book Chapters: 0